Phanero AI
  • Home
  • About
  • Validation velocity
Sign in Subscribe

The FDA are paying attention - Exer Labs Warning Letter

Avoid the compliance pitfalls that led to the Exer Labs FDA warning letter. Discover how a GxP-AI Management System (AMS) integrates AI governance into your QMS for total lifecycle oversight.
Read More

AI meets GxP: Model Cards for Trust, Transparency and Compliance

Artificial intelligence is shaking up the pharmaceutical industry, delivering efficiencies in manufacturing,
Read More

Why SaaS Vendors Are Racing to Add GenAI in Life Sciences: An Analysis of MIT’s State of AI in Business 2025

By Ben O'Brien 01/09/2025 Introduction: The Growing Impact
Read More

When “Imperfect” AI Models Still Add Value in Pharma Quality

Introduction: Quality mindset in an AI world Artificial intelligence is rapidly reshaping
Read More
Phanero AI © 2026
  • Sign up
Powered by Ghost